In the present study, we used the pan-pathogen microarray (PathoChip [ 17 ]) to screen a larger cohort of BC and control patient samples, to validate our previous small-scale study [ 3 ], and showed a trend or correlation between unique microbial signature patterns in different BC types with clinical intervention or outcomes.
1
—
—